Microsatellite instability is a predictive marker for survival benefit from adjuvant chemotherapy in a population-based series of stage III colorectal carcinoma

H Elsaleh, B Iacopetta - Clinical colorectal cancer, 2001 - Elsevier
Tumors with the microsatellite instability (MSI) phenotype appear to comprise a biologically
and clinically distinct group of colorectal carcinomas (CRC). MSI+ has been associated with …

Microsatellite Instability Is a Predictive Marker for Survival Benefit from Adjuvant Chemotherapy in a Population-Based Series of Stage III Colorectal Carcinoma

H Elsaleh, B Iacopetta - Clinical Colorectal Cancer, 2001 - infona.pl
Tumors with the microsatellite instability (MSI) phenotype appear to comprise a biologically
and clinically distinct group of colorectal carcinomas (CRC). MSI+ has been associated with …

Microsatellite instability is a predictive marker for survival benefit from adjuvant chemotherapy in a population-based series of stage III colorectal carcinoma.

H Elsaleh, B Iacopetta - Clinical Colorectal Cancer, 2001 - europepmc.org
Tumors with the microsatellite instability (MSI) phenotype appear to comprise a biologically
and clinically distinct group of colorectal carcinomas (CRC). MSI+ has been associated with …

Microsatellite Instability Is a Predictive Marker for Survival Benefit from Adjuvant Chemotherapy in a Population-Based Series of Stage III Colorectal Carcinoma

H Elsaleh, B Iacopetta - Clinical Colorectal Cancer, 2001 - clinical-colorectal-cancer.com
Tumors with the microsatellite instability (MSI) phenotype appear to comprise a biologically
and clinically distinct group of colorectal carcinomas (CRC). MSI+ has been associated with …

Microsatellite instability is a predictive marker for survival benefit from adjuvant chemotherapy in a population-based series of stage III colorectal carcinoma

H Elsaleh, B Iacopetta - Clinical colorectal cancer, 2001 - pubmed.ncbi.nlm.nih.gov
Tumors with the microsatellite instability (MSI) phenotype appear to comprise a biologically
and clinically distinct group of colorectal carcinomas (CRC). MSI+ has been associated with …

[引用][C] Microsatellite instability is a predictive marker for survival benefit from adjuvent chemotherapy in a population-based of StageIII colorectal carcinoma

H Elsaleh, B Iacopetta - Clinical Colorectal Cancer, 2001 - research-repository.uwa.edu.au
Microsatellite instability is a predictive marker for survival benefit from adjuvent chemotherapy in
a population-based of StageIII colorectal carcinoma — the UWA Profiles and Research …